📰New & Featured | New #Cell study: Ultrasensitive, longitudinal #ctDNA tracking can spot #cancer relapse months before scans do. 🩸🔬
➡️ ctDNA levels predict recurrence risk in early-stage, high-risk cancers, paving the way for personalized adjuvant therapy.
#CancerRelapse #PersonalizedTherapy
0
0
0
0